Filing Analysis

📢 Regulation FD Disclosure Filed Jun 04, 2026
⚪ LOW

Vivani Medical, Inc. filed an 8-K to disclose a presentation being given by CEO Dr. Adam Mendelsohn at the Jefferies Global Healthcare Conference on June 4, 2026. The company provided the slide deck as an exhibit to ensure public dissemination of the information.

📋 Key Facts

  • Presentation date: June 4, 2026, at 11:05 a.m. Eastern
  • Event: Jefferies Global Healthcare Conference in New York
  • Presenter: Dr. Adam Mendelsohn, Chief Executive Officer
  • The slide presentation is attached as Exhibit 99.1 and posted on the company's website
📢 Regulation FD Disclosure Filed May 13, 2026
⚪ LOW

Vivani Medical, Inc. reported its first quarter 2026 financial results and provided a business update. The filing also includes an updated corporate slide presentation for use in upcoming investor and industry conferences.

📋 Key Facts

  • Reported Q1 2026 financial results on May 13, 2026
  • Released an updated corporate slide presentation as Exhibit 99.2
  • The report was filed under Item 2.02 (Results of Operations) and Item 7.01 (Regulation FD Disclosure)
📢 Regulation FD Disclosure Filed Mar 26, 2026
⚪ LOW

Vivani Medical, Inc. filed a Form 8-K to announce its fourth quarter and full-year financial results. The filing includes a press release providing a business update alongside the financial data for the period ending December 31.

🚩 Red Flags

  • Clerical discrepancy noted: The Item 2.02 text refers to 'Full Year 2024' results, while the Exhibit 9.01 description refers to 'Full Year 2025' results.

📋 Key Facts

  • The report was filed on March 26, 2026, regarding events on the same date.
  • The filing contains Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
  • Exhibit 99.1 is a press release titled 'Vivani Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update'.
  • The company is listed on the Nasdaq Capital Market under the symbol VANI.
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for VANI

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial